Biotage AB Joins Forces With MultiSynTech GmbH And Enters the Peptide Synthesis Business
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage today announced that the company will enter the peptide synthesis business, through two new agreements with German company MultiSynTech GmbH. The agreements concern both the distribution rights for MultiSynTech’s systems and the establishment of a joint development project.